Serina Therapeutics (AMEX:SER) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.47) by 19.57 percent. This is a 16.67 percent increase over losses of $(0.66) per share from the same period last year. The company reported $130.000 thousand in sales this quarter. This is the same as the same period last year.